DxS Launches Cancer Mutation Kit For K-RAS In Australia - New Diagnostic Assists Clinicians In Selecting Appropriate Cancer Therapy For Patients

 02.07.2008 06:17   medicalnewstoday.com

DxS, a personalised medicine company and leaders in the provision of companion diagnostics, has today announced the launch of its K-RAS cancer mutation detection kit in Australia. This follows the kit meeting the compliance standards of Australia's Therapeutic Goods Administration (TGA).

World Cancer